DeepMed Research

Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Intravenous Immunoglobulin (IVIG) in Lung Transplantation

Phase 2

Completed

Conditions: Lung Transplantation
Hypogammaglobulinemia

Interventions: Drug: IVIG
Other: Placebo

First Posted Date: 2005-06-27

Last Posted Date: 2019-03-05

Lead Sponsor: Columbia University

Target Recruit Count: 11

Registration Number: NCT00115778

Locations: 🇺🇸
New York Presbyterian Hospital Lung Transplant Program, New York, New York, United States

Consortium On Risk for Early-onset Parkinson's Disease (CORE PD)

Completed

Conditions: Parkinson's Disease

First Posted Date: 2005-03-02

Last Posted Date: 2024-07-24

Lead Sponsor: Columbia University

Target Recruit Count: 750

Registration Number: NCT00104585

Locations: 🇺🇸
Columbia University, New York, New York, United States

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Phase 1

Withdrawn

Conditions: Leukemia

First Posted Date: 2003-11-24

Last Posted Date: 2012-11-19

Lead Sponsor: Columbia University

Registration Number: NCT00002761

Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma

Phase 1

Terminated

Conditions: Sarcoma

First Posted Date: 2003-01-27

Last Posted Date: 2013-02-15

Lead Sponsor: Columbia University

Registration Number: NCT00027911

Locations: 🇺🇸
Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York, United States

Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer

Terminated

Conditions: Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic/Myeloproliferative Neoplasms
Myelodysplastic Syndromes
Adult Langerhans Cell Histiocytosis
Childhood Langerhans Cell Histiocytosis

Interventions: Procedure: Peripheral Blood Stem Cell Transplantation

First Posted Date: 2003-01-27

Last Posted Date: 2014-06-06

Lead Sponsor: Columbia University

Target Recruit Count: 48

Registration Number: NCT00008216

Locations: 🇺🇸
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York, New York, United States

Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer

Not Applicable

Terminated

Conditions: Pancreatic Cancer
Malnutrition

Interventions: Drug: gemcitabine hydrochloride
Biological: proteolytic enzymes
Procedure: Gonzalez regimen

First Posted Date: 2003-01-27

Last Posted Date: 2013-02-15

Lead Sponsor: Columbia University

Target Recruit Count: 90

Registration Number: NCT00003851

Locations: 🇺🇸
Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York, United States

Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

Phase 3

Completed

Conditions: Myocardial Infarction
Heart Disease
Stroke
Ischemic Heart Disease

Interventions: Drug: aspirin
Drug: Warfarin

First Posted Date: 2002-07-22

Last Posted Date: 2014-09-05

Lead Sponsor: Columbia University

Target Recruit Count: 2305

Registration Number: NCT00041938

Locations: 🇺🇸
Albert Einstein Medical Center, Philadelphia, Pennsylvania, United States
🇺🇸
Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States
🇺🇸
Morehouse School of Medicine, Atlanta, Georgia, United States

and more 61 locations

Warfarin Versus Aspirin Recurrent Stroke Study

Phase 3

Completed

Conditions: Stroke

Interventions: Drug: Active Warfarin
Drug: Active Aspirin
Drug: Warfarin placebo
Drug: Aspirin placebo

First Posted Date: 2001-11-21

Last Posted Date: 2011-06-17

Lead Sponsor: Columbia University

Target Recruit Count: 2206

Registration Number: NCT00027066

Locations: 🇺🇸
Columbia University Health Sciences, New York, New York, United States

Depression and Health Outcomes in Refractory Epilepsy

Phase 3

Completed

Conditions: Depression
Epilepsy

Interventions: Drug: sertraline
Behavioral: cognitive behavior therapy

First Posted Date: 2001-11-15

Last Posted Date: 2017-11-06

Lead Sponsor: Columbia University

Target Recruit Count: 140

Registration Number: NCT00026637

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
Columbia University Medical Center, New York, New York, United States

The Healthy Life Choices Project in HIV-Positive Patients

Phase 2

Completed

Conditions: Diarrhea
HIV Infections

Interventions: Behavioral: Dietary intervention
Behavioral: HIV Self-Care

First Posted Date: 2001-06-14

Last Posted Date: 2021-08-17

Lead Sponsor: Columbia University

Target Recruit Count: 75

Registration Number: NCT00017810

Locations: 🇺🇸
Columbia Univ School of Nursing / Center for AIDS Research, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy